The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to Read more…
Jonathan Thomas, a founding partner of Saybrook Capital, has been nominated to lead CIRM, Read more…
The 6 W’s: The … who, what, where, when, why and what of it. Read more…
The Senate on 2/28/11 will begin debating the patent reform bill. Read more…
Join our blog community … subscribe FREE ! Do NOT miss out on daily red-hot, under the radar commentary re stock recommendations and science briefs. Read more…
TNGN was been engaged in a potential merger but, has terminated negotiations Read more…
Cell and regenerative medicine will in the future treat more severely burned service members Read more…
BrainStorm Cell Therapeutics (OTCBB: BCLI) has been granted orphan drug designation Read more…
A new stem cell “skin gun” is being developed Read more…
OSIR has appointed Stephen Potter as SVP of operations and corporate development, Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.